34 related articles for article (PubMed ID: 2819573)
1. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
2. Leiomyosarcoma of the uterus: clinicopathologic study.
Vardi JR; Tovell HM
Obstet Gynecol; 1980 Oct; 56(4):428-34. PubMed ID: 7422188
[TBL] [Abstract][Full Text] [Related]
3. [Leiomyosarcoma of the uterus--a clinicopathologic analysis of 11 cases].
He WC
Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):444-6. PubMed ID: 2076642
[TBL] [Abstract][Full Text] [Related]
4. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
[TBL] [Abstract][Full Text] [Related]
6. Leiomyosarcoma of uterus: a review of 14 cases.
Yu KJ; Ho DM; Ng HT; Chao KC; Kan YY
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Aug; 44(2):109-14. PubMed ID: 2819573
[TBL] [Abstract][Full Text] [Related]
7. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
8. Treatment of uterine leiomyosarcoma.
Berchuck A; Rubin SC; Hoskins WJ; Saigo PE; Pierce VK; Lewis JL
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):845-50. PubMed ID: 2453004
[TBL] [Abstract][Full Text] [Related]
9. Uterine Leiomyosarcoma.
Juhasz-Böss I; Gabriel L; Bohle RM; Horn LC; Solomayer EF; Breitbach GP
Oncol Res Treat; 2018; 41(11):680-686. PubMed ID: 30321869
[TBL] [Abstract][Full Text] [Related]
10. [Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment].
Hadoux J; Morice P; Lhommé C; Duvillard P; Balleyguier C; Haie-Meder C; Gouy S; Uzan C; Mazeron R; Tazi Y; Leary A; Duffaud F; Pautier P
Bull Cancer; 2013 Sep; 100(9):903-15. PubMed ID: 24004576
[TBL] [Abstract][Full Text] [Related]
11. Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
Friedman CF; Hensley ML
Curr Treat Options Oncol; 2018 Feb; 19(2):7. PubMed ID: 29417238
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]